N-acetylcysteine improves function and follicular survival in mice ovarian grafts through inhibition of oxidative stress
Adverse Reactions Occurring at an Incidence of 5% or More Among VYVANSE Treated Patients with ADHD in Clinical Trials The most common adverse reactions (incidence 5% and at a rate at least twice placebo) reported in pediatric patients ages 6 to 17 years, and/or adults were anorexia, anxiety, decreased appetite, decreased weight, diarrhea, dizziness, dry mouth, irritability, insomnia, nausea, upper abdominal pain, and vomiting
There is only a 7-day switching period, which is the same amount of time you wait between taking your weekly injections, so you should not notice much of a change
Consider a hypothetical drug doing $8 billion annually